Partial cryptophthalmia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:98950Q11.2
Who is this for?
Show terms as
View depth
8Treatment centers

Where are you in your journey?

UniteRare data is compiled from authoritative primary sources (FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, NORD), then processed through automated and AI-assisted extraction pipelines.
Report missing data

What is Partial cryptophthalmia?

Partial cryptophthalmia is a rare congenital eye malformation in which the eyelid skin partially covers the eye, with a portion of the lid fused to the underlying cornea and globe. Unlike complete cryptophthalmia, where the entire eye is covered by a continuous sheet of skin with no recognizable eyelid structures, partial cryptophthalmia retains some normal eyelid anatomy — typically the medial or lateral portion of the lid is normally formed while the remaining portion is replaced by skin fused directly to the ocular surface. The condition is present at birth and primarily affects the eye and periorbital structures. The underlying cornea in the area of fusion is often abnormal, and the conjunctival sac is reduced or absent in the affected region. Partial cryptophthalmia may occur as an isolated finding or as part of a broader syndrome, most notably Fraser syndrome (cryptophthalmia-syndactyly syndrome), which is caused by mutations in the FRAS1, FREM2, or GRIP1 genes and follows autosomal recessive inheritance. When associated with Fraser syndrome, patients may also have syndactyly, renal anomalies, genital malformations, and other developmental abnormalities. Isolated cases may occur sporadically. The condition can affect one or both eyes and may be accompanied by other ocular anomalies such as microphthalmia, symblepharon, or absence of eyebrows and eyelashes in the affected area. Management of partial cryptophthalmia is primarily surgical and aims to reconstruct functional eyelids, restore the conjunctival fornix, and protect or improve the ocular surface. Surgical approaches may include separation of the fused skin from the globe, conjunctival and eyelid reconstruction using grafts, and corneal surface rehabilitation. Visual prognosis depends on the severity of corneal and globe involvement. Early evaluation by a multidisciplinary team including ophthalmologists, oculoplastic surgeons, and clinical geneticists is recommended to assess for syndromic features and plan appropriate interventions.

Inheritance
Variable
Can be inherited in different ways depending on the underlying gene
Age of Onset
Neonatal
Begins at or shortly after birth (first 4 weeks)
Orphanet ↗NORD ↗

Treatments

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

No FDA-approved treatments are currently listed for Partial cryptophthalmia.

View clinical trials →

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

No actively recruiting trials found for Partial cryptophthalmia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial cryptophthalmia community →

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

No specialists are currently listed for Partial cryptophthalmia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

🏨 Children's

Children's Hospital Colorado Rare Disease Program

Children's Hospital Colorado

📍 Aurora, CO

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Boston Children's Hospital Rare Disease Program

Boston Children's Hospital

📍 Boston, MA

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

🏨 Children's

Ann & Robert H. Lurie Children's Hospital Genetics

Lurie Children's Hospital

📍 Chicago, IL

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

Cincinnati Children's Hospital Medical Center

Cincinnati Children's

📍 Cincinnati, OH

👤 Boston Children's Hospital Rare Disease Program

🏨 Children's

Nationwide Children's Hospital Rare Disease Center

Nationwide Children's Hospital

📍 Columbus, OH

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

Travel Grants

No travel grants are currently matched to Partial cryptophthalmia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial cryptophthalmiaForum →

No community posts yet. Be the first to share your experience with Partial cryptophthalmia.

Start the conversation →

Latest news about Partial cryptophthalmia

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

No recent news articles for Partial cryptophthalmia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial cryptophthalmia

What is Partial cryptophthalmia?

Partial cryptophthalmia is a rare congenital eye malformation in which the eyelid skin partially covers the eye, with a portion of the lid fused to the underlying cornea and globe. Unlike complete cryptophthalmia, where the entire eye is covered by a continuous sheet of skin with no recognizable eyelid structures, partial cryptophthalmia retains some normal eyelid anatomy — typically the medial or lateral portion of the lid is normally formed while the remaining portion is replaced by skin fused directly to the ocular surface. The condition is present at birth and primarily affects the eye and

At what age does Partial cryptophthalmia typically begin?

Typical onset of Partial cryptophthalmia is neonatal. Age of onset can vary across affected individuals.

Frequently asked questions about Partial cryptophthalmia

Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.

  1. What is Partial cryptophthalmia?

    Partial cryptophthalmia is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:98950). It is typically inherited as variable. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Partial cryptophthalmia page.

  2. How is Partial cryptophthalmia inherited?

    Partial cryptophthalmia follows variable inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.

  3. Are there FDA-approved treatments for Partial cryptophthalmia?

    Approved treatments for Partial cryptophthalmia are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.

  4. Are there clinical trials for Partial cryptophthalmia?

    Active clinical trials for Partial cryptophthalmia are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.

  5. How do I find a specialist for Partial cryptophthalmia?

    Verified Partial cryptophthalmia specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.

See full Partial cryptophthalmia page for complete clinical details, sources, and verified-specialist listings.

Cite this page

Select a citation format above to view and copy.